Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G.

FEBS Lett. 1994 May 23;345(1):81-6. Unique Identifier : AIDSLINE MED/94252410
Avril LE; Di Martino-Ferrer M; Pignede G; Seman M; Gauthier F; Laboratoire d'Enzymologie, Centre National de la Recherche; Scientifique URA 1334, University Francois Rabelais, Faculty of; Medicine, Tours, France.


Abstract: We have purified a serine proteinase from the membrane of U-937 cells that was inhibited in a tight-binding manner by recombinant gp120 and by peptides mimicking the V3 loop of gp120 [(1993) FEBS Lett. 317, 167-172]. This proteinase has now been characterized, both structurally and functionally. It has a dual trypsin- and chymotrypsin-like specificity, and N-terminal sequence analysis of the first 32 residues indicates complete identity with leukocyte cathepsin G. Cathepsin G-like material was located at the surface of U-937 cells using a monoclonal antibody directed against leukocyte cathepsin G, and polyclonal anti-cathepsin G antibodies precipitated the purified proteinase. However, the U-937 enzyme differs slightly from commercial leukocyte cathepsin G in its apparent M(r) because of different glycosylation. No other protein structurally related to cathepsin G was found upon screening a U-937 cDNA library using several oligonucleotide probes constructed from the membrane proteinase N-terminal amino acid sequence. The possible interaction of a cathepsin G-like proteinase at the surface of U-937 cells with the V3 loop of HIV-1 gp120 is discussed.
Keywords: Amino Acid Sequence Base Sequence Cathepsins/IMMUNOLOGY/*ISOLATION & PURIF/*METABOLISM Cell Membrane/*ENZYMOLOGY Cross Reactions DNA, Complementary/GENETICS Human HIV Envelope Protein gp120/*METABOLISM Immunoblotting Leukocytes/ENZYMOLOGY Molecular Sequence Data Oligonucleotide Probes Peptide Fragments/*METABOLISM Sequence Analysis Substrate Specificity Support, Non-U.S. Gov't Tumor Cells, Cultured JOURNAL ARTICLE

KWDaminoacidsequencebasesequencecathepsins/immunology/KWDisolation&purif/KWDmetabolismcellmembrane/KWDenzymologycrossreactionsdna,complementary/geneticshumanhivenvelopeproteingp120/KWDmetabolismimmunoblottingleukocytes/enzymologymolecularsequencedataoligonucleotideprobespeptidefragments/KWDmetabolismsequenceanalysissubstratespecificitysupport,non-uKWDsKWDgov'ttumorcells,culturedjournalarticle
940930
M9490997


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .